Presidio Management Group XII, L.L.C. 4

Accession 0001548538-20-000027

CIK 0001671858other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 9:04 PM ET

Size

25.1 KB

Accession

0001548538-20-000027

Form 4

Period: 2020-12-08

10% Owner

Transactions

Conversion
Preferred Series B Stock
2020-12-08−6,609,027→ 0 total(indirect: By U.S. Venture Partners XII, L.P.)
→ Common Stock (1,779,969 underlying)
Conversion
Common Stock
2020-12-08+90,335→ 90,335 total(indirect: By U.S. Venture Partners XII-A, L.P.)
Conversion
Preferred Series C Stock
2020-12-08−1,073,793→ 0 total(indirect: By U.S. Venture Partners XII, L.P.)
→ Common Stock (289,198 underlying)
Conversion
Common Stock
2020-12-08+1,779,969→ 1,779,969 total(indirect: By U.S. Venture Partners XII, L.P.)
Conversion
Common Stock
2020-12-08+289,198→ 2,069,167 total(indirect: By U.S. Venture Partners XII, L.P.)
Conversion
Preferred Series B Stock
2020-12-08−335,417→ 0 total(indirect: By U.S. Venture Partners XII-A, L.P.)
→ Common Stock (90,335 underlying)
Purchase
Common Stock
2020-12-08$21.00/sh+47,619$999,999→ 47,619 total(indirect: Directly owned by Tansey)
Conversion
Common Stock
2020-12-08+14,677→ 105,012 total(indirect: By U.S. Venture Partners XII-A, L.P.)
Conversion
Preferred Series C Stock
2020-12-08−54,496→ 0 total(indirect: By U.S. Venture Partners XII-A, L.P.)
→ Common Stock (14,677 underlying)

10% Owner

Transactions

Conversion
Preferred Series C Stock
2020-12-08−54,496→ 0 total(indirect: By U.S. Venture Partners XII-A, L.P.)
→ Common Stock (14,677 underlying)
Conversion
Common Stock
2020-12-08+289,198→ 2,069,167 total(indirect: By U.S. Venture Partners XII, L.P.)
Purchase
Common Stock
2020-12-08$21.00/sh+47,619$999,999→ 47,619 total(indirect: Directly owned by Tansey)
Conversion
Preferred Series B Stock
2020-12-08−6,609,027→ 0 total(indirect: By U.S. Venture Partners XII, L.P.)
→ Common Stock (1,779,969 underlying)
Conversion
Preferred Series B Stock
2020-12-08−335,417→ 0 total(indirect: By U.S. Venture Partners XII-A, L.P.)
→ Common Stock (90,335 underlying)
Conversion
Common Stock
2020-12-08+1,779,969→ 1,779,969 total(indirect: By U.S. Venture Partners XII, L.P.)
Conversion
Common Stock
2020-12-08+90,335→ 90,335 total(indirect: By U.S. Venture Partners XII-A, L.P.)
Conversion
Common Stock
2020-12-08+14,677→ 105,012 total(indirect: By U.S. Venture Partners XII-A, L.P.)
Conversion
Preferred Series C Stock
2020-12-08−1,073,793→ 0 total(indirect: By U.S. Venture Partners XII, L.P.)
→ Common Stock (289,198 underlying)

10% Owner

Transactions

Conversion
Common Stock
2020-12-08+1,779,969→ 1,779,969 total(indirect: By U.S. Venture Partners XII, L.P.)
Conversion
Common Stock
2020-12-08+90,335→ 90,335 total(indirect: By U.S. Venture Partners XII-A, L.P.)
Purchase
Common Stock
2020-12-08$21.00/sh+47,619$999,999→ 47,619 total(indirect: Directly owned by Tansey)
Conversion
Preferred Series C Stock
2020-12-08−1,073,793→ 0 total(indirect: By U.S. Venture Partners XII, L.P.)
→ Common Stock (289,198 underlying)
Conversion
Common Stock
2020-12-08+289,198→ 2,069,167 total(indirect: By U.S. Venture Partners XII, L.P.)
Conversion
Common Stock
2020-12-08+14,677→ 105,012 total(indirect: By U.S. Venture Partners XII-A, L.P.)
Conversion
Preferred Series C Stock
2020-12-08−54,496→ 0 total(indirect: By U.S. Venture Partners XII-A, L.P.)
→ Common Stock (14,677 underlying)
Conversion
Preferred Series B Stock
2020-12-08−6,609,027→ 0 total(indirect: By U.S. Venture Partners XII, L.P.)
→ Common Stock (1,779,969 underlying)
Conversion
Preferred Series B Stock
2020-12-08−335,417→ 0 total(indirect: By U.S. Venture Partners XII-A, L.P.)
→ Common Stock (90,335 underlying)

10% Owner

Transactions

Conversion
Common Stock
2020-12-08+289,198→ 2,069,167 total(indirect: By U.S. Venture Partners XII, L.P.)
Conversion
Common Stock
2020-12-08+14,677→ 105,012 total(indirect: By U.S. Venture Partners XII-A, L.P.)
Conversion
Preferred Series B Stock
2020-12-08−6,609,027→ 0 total(indirect: By U.S. Venture Partners XII, L.P.)
→ Common Stock (1,779,969 underlying)
Conversion
Preferred Series C Stock
2020-12-08−54,496→ 0 total(indirect: By U.S. Venture Partners XII-A, L.P.)
→ Common Stock (14,677 underlying)
Conversion
Common Stock
2020-12-08+1,779,969→ 1,779,969 total(indirect: By U.S. Venture Partners XII, L.P.)
Conversion
Common Stock
2020-12-08+90,335→ 90,335 total(indirect: By U.S. Venture Partners XII-A, L.P.)
Purchase
Common Stock
2020-12-08$21.00/sh+47,619$999,999→ 47,619 total(indirect: Directly owned by Tansey)
Conversion
Preferred Series B Stock
2020-12-08−335,417→ 0 total(indirect: By U.S. Venture Partners XII-A, L.P.)
→ Common Stock (90,335 underlying)
Conversion
Preferred Series C Stock
2020-12-08−1,073,793→ 0 total(indirect: By U.S. Venture Partners XII, L.P.)
→ Common Stock (289,198 underlying)

Footnotes (3)

[F1]The shares were purchased in the Issuer's initial public offering.
[F2]Series B and Series C Preferred Stock automatically converted into shares of the Issuer's Common Stock immediately upon the closing of the Issuer's imitial public offering, for no additional consideration at a rate of 1 share of Common Stock for each 3.713 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock had no expiration date.
[F3]Presidio Management Group XII, L.L.C. ("PMG XII"), the general partner of each of U.S. Venture Partners XII, L.P. and U.S. Venture Partners XII-A, L.P. (together, the "USVP XII Funds"), has sole voting and dispositive power with respect to the shares held by the USVP XII. Casey Tansey is the sole managing partner of PMG XII and may be deemed to have voting and dispositive power over the reported securities held by the USVP XII Funds, and each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.

Documents

1 file

Silverback Therapeutics, Inc.

CIK 0001671858

Entity typeother

IncorporatedDE